Caitlin Cronin
Stock Analyst at Canaccord Genuity
(3.99)
# 546
Out of 5,146 analysts
47
Total ratings
51.43%
Success rate
14.4%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Caitlin Cronin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Buy | $105 → $112 | $96.22 | +16.40% | 3 | Jan 9, 2026 | |
| ENOV Enovis | Maintains: Buy | $58 → $50 | $22.32 | +124.01% | 4 | Dec 17, 2025 | |
| INMD InMode | Maintains: Hold | $16 → $15 | $13.96 | +7.45% | 6 | Dec 17, 2025 | |
| ESTA Establishment Labs Holdings | Maintains: Buy | $72 → $85 | $78.29 | +8.57% | 3 | Dec 17, 2025 | |
| AXGN Axogen | Maintains: Buy | $27 → $37 | $31.22 | +18.51% | 8 | Dec 5, 2025 | |
| TELA TELA Bio | Maintains: Buy | $7 → $4 | $0.85 | +371.75% | 5 | Nov 18, 2025 | |
| SNN Smith & Nephew | Maintains: Hold | $36 → $34 | $36.29 | -6.31% | 4 | Nov 11, 2025 | |
| ATEC Alphatec Holdings | Maintains: Buy | $20 → $25 | $14.04 | +78.06% | 5 | Oct 31, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $58 | $37.09 | +56.38% | 4 | Aug 1, 2025 | |
| BVS Bioventus | Maintains: Buy | $15 | $8.75 | +71.43% | 1 | Mar 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $3 → $4 | $4.92 | -18.70% | 2 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $130 | $99.85 | +30.20% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $270 → $12 | $2.07 | +479.71% | 1 | Nov 14, 2023 |
Globus Medical
Jan 9, 2026
Maintains: Buy
Price Target: $105 → $112
Current: $96.22
Upside: +16.40%
Enovis
Dec 17, 2025
Maintains: Buy
Price Target: $58 → $50
Current: $22.32
Upside: +124.01%
InMode
Dec 17, 2025
Maintains: Hold
Price Target: $16 → $15
Current: $13.96
Upside: +7.45%
Establishment Labs Holdings
Dec 17, 2025
Maintains: Buy
Price Target: $72 → $85
Current: $78.29
Upside: +8.57%
Axogen
Dec 5, 2025
Maintains: Buy
Price Target: $27 → $37
Current: $31.22
Upside: +18.51%
TELA Bio
Nov 18, 2025
Maintains: Buy
Price Target: $7 → $4
Current: $0.85
Upside: +371.75%
Smith & Nephew
Nov 11, 2025
Maintains: Hold
Price Target: $36 → $34
Current: $36.29
Upside: -6.31%
Alphatec Holdings
Oct 31, 2025
Maintains: Buy
Price Target: $20 → $25
Current: $14.04
Upside: +78.06%
Vericel
Aug 1, 2025
Maintains: Buy
Price Target: $61 → $58
Current: $37.09
Upside: +56.38%
Bioventus
Mar 17, 2025
Maintains: Buy
Price Target: $15
Current: $8.75
Upside: +71.43%
Nov 14, 2024
Maintains: Buy
Price Target: $3 → $4
Current: $4.92
Upside: -18.70%
Feb 23, 2024
Reiterates: Hold
Price Target: $130
Current: $99.85
Upside: +30.20%
Nov 14, 2023
Downgrades: Hold
Price Target: $270 → $12
Current: $2.07
Upside: +479.71%